MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stake in HCA Healthcare, Inc. (NYSE:HCA)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 19.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,756 shares of the company's stock after selling 5,562 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in HCA Healthcare were worth $6,830,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of HCA. Whipplewood Advisors LLC bought a new stake in HCA Healthcare during the 4th quarter valued at about $31,000. Tidemark LLC purchased a new position in HCA Healthcare in the 4th quarter worth approximately $36,000. Activest Wealth Management boosted its stake in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after purchasing an additional 125 shares during the last quarter. Legacy Investment Solutions LLC raised its stake in shares of HCA Healthcare by 99.0% in the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after purchasing an additional 95 shares during the last quarter. Finally, Physician Wealth Advisors Inc. purchased a new position in HCA Healthcare in the 4th quarter worth about $64,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages recently commented on HCA. Royal Bank of Canada cut their price objective on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Robert W. Baird reiterated a "neutral" rating and set a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Monday, April 28th. Bank of America decreased their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research note on Monday, January 27th. Finally, Guggenheim started coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $381.13.

HCA Healthcare Trading Down 1.1%

HCA traded down $4.23 on Thursday, hitting $377.59. The company had a trading volume of 779,727 shares, compared to its average volume of 1,433,734. The company has a market cap of $90.84 billion, a PE ratio of 17.19, a PEG ratio of 1.10 and a beta of 1.46. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The business's fifty day simple moving average is $344.86 and its 200 day simple moving average is $329.27. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The company had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. During the same period last year, the company earned $5.36 earnings per share. HCA Healthcare's revenue was up 5.7% on a year-over-year basis. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. HCA Healthcare's dividend payout ratio is 12.81%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.